EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study

Bodo Speckmann, Tanja Wagner, Paul M Jordan iD, Oliver Werz iD, Manfred Wilhelm iD, Heike Tom Dieck, Christiane Schön iD

Nutrients · 2024

DOI: 10.3390/nu16091354 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Bodo Speckmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Evonik Operations GmbH, Rodenbacher Chaussee 4, 63457 Hanau, Germany. Hauptthemen laut MEDLINE: Bacillus megaterium, Fatty Acids, Omega-3, Synbiotics, Eicosapentaenoic Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Evonik Operations GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beneficial health effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) are partly attributed to specialized pro-resolving mediators (SPMs), which promote inflammation resolution. Strategies to improve n-3 PUFA conversion to SPMs may, therefore, be useful to treat or prevent chronic inflammatory disorders. Here, we explored a synbiotic strategy to increase circulating SPM precursor levels. Healthy participants (n = 72) received either SynΩ3 (250 mg eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) lysine salts; two billion CFU Bacillus megaterium; n = 23), placebo (n = 24), or fish oil (300 mg EPA plus DHA; N = 25) capsules daily for 28 days in a randomized, double-blind placebo-controlled parallel 3-group design. Biomarkers were assessed at baseline and after 2 and 28 days of intervention. The primary analysis involved the comparison between SynΩ3 and placebo. In addition, SynΩ3 was compared to fish oil. The synbiotic SynΩ3 comprising Bacillus megaterium DSM 32963 and n-3 PUFA salts significantly increased circulating SPM precursor levels, including 18-hydroxy-eicosapentaenoic acid (18-HEPE) plus 5-HEPE, which was not achieved to this extent by fish oil with a similar n-3 PUFA content. Omega-3 indices were increased slightly by both SynΩ3 and fish oil. These findings suggest reconsidering conventional n-3 PUFA supplementation and testing the effectiveness of SynΩ3 particularly in conditions related to inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus megateriumFatty Acids, Omega-3SynbioticsEicosapentaenoic AcidHumansMaleFemaleAdultDouble-Blind MethodYoung AdultDocosahexaenoic AcidsMiddle AgedBiomarkersHealthy VolunteersFish Oils

Stichwörter der Autor:innen

Bacillus megateriuminflammation resolutionmetabioticnutritional therapyomega-3probioticspecialized pro-resolving mediators

Substanzen

Fatty Acids, Omega-3Eicosapentaenoic AcidDocosahexaenoic AcidsBiomarkersFish Oils

Autor:innen und Institutionen

  • Evonik Operations GmbH, Rodenbacher Chaussee 4, 63457 Hanau, Germany.
  • BioTeSys GmbH, Schelztorstrasse 54-56, 73728 Esslingen, Germany.
  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743 Jena, Germany.
  • Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, 07743 Jena, Germany.
  • Department of Mathematics, Natural and Economic Sciences, Ulm University of Applied Sciences, 89081 Ulm, Germany.

ORCID-Profile: Paul M Jordan, Oliver Werz, Manfred Wilhelm, Christiane Schön

Förderung

  • Evonik Operations GmbH

Zitieren

APA

Speckmann, B., Wagner, T., Jordan, P. M., Werz, O., Wilhelm, M., Tom Dieck, H., & Schön, C. (2024). Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study. Nutrients. https://doi.org/10.3390/nu16091354

Vancouver

Speckmann B, Wagner T, Jordan PM, Werz O, Wilhelm M, Tom Dieck H, et al. Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study. Nutrients. 2024. doi:10.3390/nu16091354

BibTeX
@article{Speckmann2024,
  author = {Speckmann, Bodo and Wagner, Tanja and Jordan, Paul M and Werz, Oliver and Wilhelm, Manfred and Tom Dieck, Heike and Schön, Christiane},
  title = {Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16091354}
}
Kostenlos starten →